Nike’s gloomy forecast puts spotlight on N America slowdown

By Granth Vanaik, Ananya Mariam Rajesh and Katherine Masters (Reuters) -Nike forecast first-quarter revenue below Wall Street expectations on Thursday as cost-conscious consumers in North America cut back on sneaker and sports apparel purchases overshadowing a strong recovery in China. In North America, the company’s biggest market, still-high inflation has led to consumers buying essential…

Read More

Alkermes wins battle against Sarissa in closely watched boardroom fight

By Svea Herbst-Bayliss NEW YORK (Reuters) -Alkermes beat back activist investor Sarissa Capital Management’s boardroom challenge on Thursday when shareholders re-elected all of the biotechnology company’s directors in one of the year’s most closely watched votes. Sarissa, one of Alkermes’ biggest investors with an 8.5% stake, criticized how management is running the company and how…

Read More

IMF board completes Ukraine loan review, allowing $890 million withdrawal

By David Lawder and Andrea Shalal WASHINGTON (Reuters) -The International Monetary Fund’s executive board on Thursday completed its first review of Ukraine’s $15.6 billion loan program, allowing Kyiv to immediately withdraw $890 million for budget support as it mounts a major offensive against Russia’s invasion. The board’s approval brings Ukraine’s withdrawals under the program launched…

Read More

Hold the Ozempic before surgery, US doctors say

By Julie Steenhuysen CHICAGO (Reuters) – People taking popular diabetes and weight loss drugs such as Novo Nordisk’s Ozempic and Wegovy or Eli Lilly’s Mounjaro should temporarily stop taking them before having elective surgery to avoid possible serious complications, the American Society of Anesthesiologists (ASA) said on Thursday. The group has received anecdotal reports from…

Read More

Brazil government sets new 2026 inflation target, tweaks fulfillment time frame

By Victor Borges and Marcela Ayres BRASILIA (Reuters) -Brazil’s National Monetary Council (CMN), the country’s top economic policy body, decided on Thursday to set its 2026 inflation target at 3% and tweak the time frame to assess the inflation goal’s fulfillment, confirming market expectations on both fronts. Currently, the CMN sets annual inflation targets that…

Read More

US FDA approves BioMarin’s gene therapy for hemophilia A

By Nathan Gomes (Reuters) -The U.S. Food and Drug Administration on Thursday approved BioMarin Pharmaceutical’s gene therapy for severe hemophilia A, the company said, giving patients with the inherited bleeding disorder an alternative to regular injections of missing blood proteins. It priced the one-time therapy, Roctavian, at $2.9 million. Pivotal trial results showed that Roctavian…

Read More

Volkswagen in talks with Tesla to adopt its charging standard

(Reuters) -Volkswagen is in talks with Tesla to adopt its North American Charging Standard (NACS) technology, while the German automaker’s charging network unit Electrify America has already agreed to use the system. The announcement comes as a slew of automakers and charging equipment makers choose Tesla’s charging design on concerns of losing out on customers…

Read More